Healthcare

Leading advisory services for the healthcare industry.

The healthcare landscape is rapidly evolving, driven by technological advancements and a growing focus on longevity and well-being. This creates an abundance of opportunity for companies operating in this dynamic market.

Oppenheimer's Healthcare Investment Banking Group is dedicated to serving the needs of clients across life sciences, healthcare services and value-based care, health tech, and med tech. With a deep understanding of the industry and extensive transaction experience, our specialized teams provide expert guidance to help clients achieve their strategic and financial goals.

Our comprehensive range of services includes acting as advisors for both buy- and sell-side transactions, as well as underwriting and placing equity and debt offerings for public and privately-held healthcare firms. Over the past decade, our healthcare banking professionals have successfully facilitated financings that raised around $30 billion and advised on over 300 merger and acquisition deals totaling approximately $13 billion in value.*

^{*Includes certain transactions completed prior to Oppenheimer’s acquisition in January 2008 of some of CIBC World Markets’ investment banking and capital markets businesses in the U.S., Israel, Europe, and Asia.}

Our healthcare banking professionals focus on the following sub-sectors:

Recent Transactions

Our Team

Life Sciences

Healthcare Services and Value-Based Care

Health Tech

Med Tech

Healthcare Mergers and Acquisitions

European Healthcare